Australia looks to add local mRNA manufacturing capability Share The manufacture of future COVID-19 vaccine boosters and annual flu shots could be supported by early-stage plans for domestic production of mRNA vaccines in Australia. Preliminary discussions and the development of a business case are under way, as the Morrison government faces continued pressure over supply problems related to overseas-produced COVID-19 vaccines. The locally produced AstraZeneca vaccine is being made by CSL-owned company Seqirus in Melbourne. A regional manufacturing hub for mRNA vaccine technology products would give Australia capability to make vaccines like the Pfizer and Moderna COVID-19 locally, strengthening the response to future public health emergencies.